Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2701 | 2021 |
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses WHOST Consortium The Lancet, 2022 | 269 | 2022 |
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study H Poustchi, M Darvishian, Z Mohammadi, A Shayanrad, A Delavari, ... The Lancet Infectious Diseases 21 (4), 473-481, 2021 | 181 | 2021 |
Can COVID-19 present unusual GI symptoms A Hormati, A Shahhamzeh, M Afifian, F Khodadust, S Ahmadpour J Microbiol Immunol Infect 53 (3), 384-385, 2020 | 65 | 2020 |
Mental health advice for frontline healthcare providers caring for patients with COVID-19 R Alikhani, A Salimi, A Hormati, R Aminnejad Canadian Journal of Anesthesia/Journal canadien d'anesthésie 67, 1068-1069, 2020 | 31 | 2020 |
SD1000: high sustained viral response rate in 1361 patients with hepatitis C genotypes 1, 2, 3, and 4 using a low-cost, fixed-dose combination tablet of generic sofosbuvir and … S Merat Clinical infectious diseases 70 (10), 2206-2212, 2020 | 29 | 2020 |
The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment H Poustchi, S Majd Jabbari, S Merat, AH Sharifi, AA Shayesteh, ... Journal of Gastroenterology and Hepatology 35 (9), 1590-1594, 2020 | 28 | 2020 |
Clinical manifestations of gastrointestinal symptoms in COVID-19 patients: an integrative review M Abbasinia, A Hormati, SKE Hossaini, SYF Ghomi, F Zamani, M Afifian, ... Gastroenterology Nursing 44 (1), E1-E10, 2021 | 27 | 2021 |
Nonadherence to medication in inflammatory bowel disease: rate and reasons MR Ghadir, M Bagheri, H Vahedi, NE Daryani, R Malekzadeh, A Hormati, ... Middle East Journal of Digestive Diseases 8 (2), 116, 2016 | 23 | 2016 |
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER) S Mobarak, M Salasi, A Hormati, J Khodadadi, M Ziaee, F Abedi, ... Journal of Antimicrobial Chemotherapy 77 (3), 758-766, 2022 | 22 | 2022 |
Are there any association between COVID-19 severity and immunosuppressive therapy? A Hormati, MR Ghadir, F Zamani, J Khodadadi, F Khodadust, M Afifian, ... Immunology Letters 224, 12, 2020 | 21 | 2020 |
Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial. SS Sarkeshikian, MR Ghadir, F Alemi, SM Jalali, A Hormati, ... Journal of Gastroenterology and Hepatology, 2019 | 21 | 2019 |
Migraine and gastric disorders: Are they associated? A Hormati, N Akbari, E Sharifipour, SA Hejazi, F Jafari, F Alemi, ... Journal of Research in Medical Sciences 24 (1), 60, 2019 | 21 | 2019 |
Migraine, Dyspepsia and Helicobacter Pylori: Zeroing in on the Culprit E Akbari, Nayereh , Hormati, Ahmad , Sharifipour Iranian Journal of Neurology, 2019 | 18 | 2019 |
Endoscopic mucosal resection: still a reliable therapeutic option for gastrointestinal neuroendocrine tumors GR Sivandzadeh, F Ejtehadi, S Shoaee, L Aminlari, R Niknam, ... BMC gastroenterology 21, 1-6, 2021 | 17 | 2021 |
Prevalence of Anesthetic and Gastrointestinal Complications of Endoscopic Retrograde Cholangiopancreatography A Hormati, R Aminnejad, M Saeidi, MR Ghadir, A Mohammadbeigi, ... Anesthesiology and Pain Medicine, 2019 | 16 | 2019 |
Preventive strategies used by GI physicians during the COVID-19 pandemic A Hormati, MR Ghadir, F Zamani, J Khodadadi, M Afifian, S Ahmadpour New Microbes and New Infections 35, 2020 | 15 | 2020 |
Mesalazine has no effect on mucosal immune biomarkers in patients with diarrhea-dominant irritable bowel syndrome referred to Shariati Hospital: a randomized double-blind … MR Ghadir, M Poradineh, M Sotodeh, R Ansari, S Kolahdoozan, ... Middle East Journal of Digestive Diseases 9 (1), 20, 2017 | 14 | 2017 |
Evaluation of anti-tumor potential of Lactobacillus acidophilus ATCC4356 culture supernatants in MCF-7 breast cancer R Behzadi, A Hormati, K Eivaziatashbeik, S Ahmadpour, F Khodadust, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2021 | 12 | 2021 |
Radioprotective effects of montelukast, a selective leukotriene CysLT1 receptor antagonist, against nephrotoxicity induced by gamma radiation in mice A Hormati, S Ahmadpour, M Afkhami Ardekani, F Khodadust, S Refahi Journal of Biochemical and Molecular Toxicology, e22479, 2020 | 12 | 2020 |